vs
La Rosa Holdings Corp.（LRHC）与礼来（RNA）财务数据对比。点击上方公司名可切换其他公司
La Rosa Holdings Corp.的季度营收约是礼来的1.6倍（$20.2M vs $12.5M），La Rosa Holdings Corp.净利率更高（-27.4% vs -1398.3%，领先1371.0%），礼来同比增速更快（434.0% vs 3.2%），过去两年礼来的营收复合增速更高（138.5% vs 72.5%）
拉罗萨控股旗下的万拉罗萨父子通心粉公司由西西里移民文森佐·拉罗萨于1914年创立，发展至今已成为美国规模领先的区域知名食品品牌，可生产四十余种意面产品，在当地市场拥有较高的认可度。
礼来是总部位于美国印第安纳州印第安纳波利斯的跨国制药企业，在18个国家设有办事处，产品销往全球约125个国家。公司由美国内战时期联邦军退伍军人、药剂师伊莱·礼来于1876年创立，品牌名即取自创始人姓名。
LRHC vs RNA — 直观对比
营收规模更大
LRHC
是对方的1.6倍
$12.5M
营收增速更快
RNA
高出430.9%
3.2%
净利率更高
LRHC
高出1371.0%
-1398.3%
两年增速更快
RNA
近两年复合增速
72.5%
损益表 — Q3 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $20.2M | $12.5M |
| 净利润 | $-5.5M | $-174.4M |
| 毛利率 | 8.4% | — |
| 营业利润率 | -24.7% | -1513.5% |
| 净利率 | -27.4% | -1398.3% |
| 营收同比 | 3.2% | 434.0% |
| 净利润同比 | -125.7% | -117.0% |
| 每股收益（稀释后） | $-5.44 | $-1.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LRHCRNA
| Q3 25 | $20.2M | $12.5M | ||
| Q2 25 | $23.2M | $3.8M | ||
| Q1 25 | $17.5M | $1.6M | ||
| Q4 24 | $17.7M | $3.0M | ||
| Q3 24 | $19.6M | $2.3M | ||
| Q2 24 | $19.1M | $2.0M | ||
| Q1 24 | $13.1M | $3.5M | ||
| Q4 23 | — | $2.2M |
净利润LRHCRNA
| Q3 25 | $-5.5M | $-174.4M | ||
| Q2 25 | $78.4M | $-157.3M | ||
| Q1 25 | $-95.7M | $-115.8M | ||
| Q4 24 | $-5.1M | $-102.3M | ||
| Q3 24 | $-2.5M | $-80.4M | ||
| Q2 24 | $-2.3M | $-70.8M | ||
| Q1 24 | $-4.6M | $-68.9M | ||
| Q4 23 | — | $-60.4M |
毛利率LRHCRNA
| Q3 25 | 8.4% | — | ||
| Q2 25 | 8.0% | — | ||
| Q1 25 | 8.8% | — | ||
| Q4 24 | 8.9% | — | ||
| Q3 24 | 8.3% | — | ||
| Q2 24 | 8.3% | — | ||
| Q1 24 | 8.9% | — | ||
| Q4 23 | — | — |
营业利润率LRHCRNA
| Q3 25 | -24.7% | -1513.5% | ||
| Q2 25 | -10.6% | -4448.7% | ||
| Q1 25 | -26.7% | -8360.9% | ||
| Q4 24 | -17.1% | -4069.6% | ||
| Q3 24 | -8.9% | -4200.9% | ||
| Q2 24 | -9.7% | -4040.4% | ||
| Q1 24 | -35.0% | -2178.6% | ||
| Q4 23 | — | -3043.5% |
净利率LRHCRNA
| Q3 25 | -27.4% | -1398.3% | ||
| Q2 25 | 337.8% | -4089.3% | ||
| Q1 25 | -546.5% | -7360.0% | ||
| Q4 24 | -28.7% | -3439.5% | ||
| Q3 24 | -12.5% | -3441.7% | ||
| Q2 24 | -12.2% | -3461.8% | ||
| Q1 24 | -35.1% | -1943.4% | ||
| Q4 23 | — | -2756.2% |
每股收益（稀释后）LRHCRNA
| Q3 25 | $-5.44 | $-1.27 | ||
| Q2 25 | $15.25 | $-1.21 | ||
| Q1 25 | $-5.86 | $-0.90 | ||
| Q4 24 | $28.54 | $-0.80 | ||
| Q3 24 | $-16.49 | $-0.65 | ||
| Q2 24 | $-12.49 | $-0.65 | ||
| Q1 24 | $-0.35 | $-0.79 | ||
| Q4 23 | — | $-0.80 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.0M | $350.2M |
| 总债务越低越好 | $642.8K | — |
| 股东权益账面价值 | $1.6M | $1.9B |
| 总资产 | $21.7M | $2.1B |
| 负债/权益比越低杠杆越低 | 0.41× | — |
8季度趋势，按日历期对齐
现金及短期投资LRHCRNA
| Q3 25 | $4.0M | $350.2M | ||
| Q2 25 | $5.1M | $243.9M | ||
| Q1 25 | $2.9M | $254.2M | ||
| Q4 24 | $1.4M | $219.9M | ||
| Q3 24 | $1.8M | $370.2M | ||
| Q2 24 | $1.6M | $575.8M | ||
| Q1 24 | $1.1M | $471.4M | ||
| Q4 23 | — | $185.1M |
总债务LRHCRNA
| Q3 25 | $642.8K | — | ||
| Q2 25 | $644.3K | — | ||
| Q1 25 | $645.9K | — | ||
| Q4 24 | $647.6K | — | ||
| Q3 24 | $649.2K | — | ||
| Q2 24 | $650.8K | — | ||
| Q1 24 | $652.4K | — | ||
| Q4 23 | — | — |
股东权益LRHCRNA
| Q3 25 | $1.6M | $1.9B | ||
| Q2 25 | $3.4M | $1.2B | ||
| Q1 25 | $-87.5M | $1.3B | ||
| Q4 24 | $2.6M | $1.4B | ||
| Q3 24 | $5.0M | $1.5B | ||
| Q2 24 | $4.7M | $1.2B | ||
| Q1 24 | $5.6M | $830.9M | ||
| Q4 23 | — | $500.8M |
总资产LRHCRNA
| Q3 25 | $21.7M | $2.1B | ||
| Q2 25 | $22.9M | $1.4B | ||
| Q1 25 | $21.0M | $1.5B | ||
| Q4 24 | $19.4M | $1.6B | ||
| Q3 24 | $19.7M | $1.6B | ||
| Q2 24 | $18.7M | $1.3B | ||
| Q1 24 | $16.3M | $951.5M | ||
| Q4 23 | — | $628.6M |
负债/权益比LRHCRNA
| Q3 25 | 0.41× | — | ||
| Q2 25 | 0.19× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.25× | — | ||
| Q3 24 | 0.13× | — | ||
| Q2 24 | 0.14× | — | ||
| Q1 24 | 0.12× | — | ||
| Q4 23 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.3M | $-156.2M |
| 自由现金流经营现金流 - 资本支出 | — | $-156.9M |
| 自由现金流率自由现金流/营收 | — | -1257.6% |
| 资本支出强度资本支出/营收 | — | 5.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-592.3M |
8季度趋势，按日历期对齐
经营现金流LRHCRNA
| Q3 25 | $-1.3M | $-156.2M | ||
| Q2 25 | $-1.4M | $-199.7M | ||
| Q1 25 | $-3.5M | $-124.8M | ||
| Q4 24 | $-1.1M | $-99.9M | ||
| Q3 24 | $-591.6K | $-65.6M | ||
| Q2 24 | $-803.1K | $-65.0M | ||
| Q1 24 | $-538.3K | $-70.4M | ||
| Q4 23 | — | $16.5M |
自由现金流LRHCRNA
| Q3 25 | — | $-156.9M | ||
| Q2 25 | — | $-203.0M | ||
| Q1 25 | — | $-128.6M | ||
| Q4 24 | — | $-103.8M | ||
| Q3 24 | — | $-67.3M | ||
| Q2 24 | — | $-65.5M | ||
| Q1 24 | — | $-71.3M | ||
| Q4 23 | — | $15.6M |
自由现金流率LRHCRNA
| Q3 25 | — | -1257.6% | ||
| Q2 25 | — | -5277.1% | ||
| Q1 25 | — | -8174.3% | ||
| Q4 24 | — | -3491.0% | ||
| Q3 24 | — | -2881.8% | ||
| Q2 24 | — | -3204.6% | ||
| Q1 24 | — | -2012.3% | ||
| Q4 23 | — | 713.1% |
资本支出强度LRHCRNA
| Q3 25 | — | 5.7% | ||
| Q2 25 | — | 86.9% | ||
| Q1 25 | — | 238.6% | ||
| Q4 24 | — | 131.7% | ||
| Q3 24 | — | 72.9% | ||
| Q2 24 | — | 26.0% | ||
| Q1 24 | — | 25.8% | ||
| Q4 23 | — | 39.4% |
现金转化率LRHCRNA
| Q3 25 | — | — | ||
| Q2 25 | -0.02× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LRHC
| Real Estate Residential Brokerage Services | $16.8M | 83% |
| Transferred Over Time | $3.5M | 17% |
RNA
暂无分部数据
